Publications by authors named "Veronika Smotkova Kraiczova"

Despite the shared pattern of surface antigens, neoplastic cells in chronic lymphocytic leukemia (CLL) are highly heterogeneous in CD5 expression, a marker linked to a proliferative pool of neoplastic cells. To further characterize CD5 and CD5 neoplastic cells, we assessed the chemokine receptors (CCR5, CCR7, CCR10, CXCR3, CXCR4, CXCR5) and adhesion molecules (CD54, CD62L, CD49d) on the CD5 and CD5 subpopulations, defined by CD5/CD19 coexpression, in peripheral blood of CLL patients ( = 60) subgrouped according to the mutational status ( , = 24; , = 36). CD5 subpopulation showed a high percentage of CXCR3 ( < 0.

View Article and Find Full Text PDF

Inflammation has received considerable attention in the pathogenesis of type 2 diabetes mellitus (T2DM). Supporting this concept, enhanced expression of interleukin (IL)-1β and increased infiltration of macrophages are observed in pancreatic islets of patients with T2DM. Although IL-1 receptor antagonist (IL-1Ra) plays a major role in controlling of IL-1β-mediated inflammation, its counteraction effects and epigenetic alterations in T2DM are less studied.

View Article and Find Full Text PDF

S-nitrosoglutathione reductase (GSNOR) exerts crucial roles in the homeostasis of nitric oxide (NO) and reactive nitrogen species (RNS) in plant cells through indirect control of S-nitrosation, an important protein post-translational modification in signaling pathways of NO. Using cultivated and wild tomato species, we studied GSNOR function in interactions of key enzymes of reactive oxygen species (ROS) metabolism with RNS mediated by protein S-nitrosation during tomato root growth and responses to salinity and cadmium. Application of a GSNOR inhibitor N6022 increased both NO and S-nitrosothiol levels and stimulated root growth in both genotypes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the activation of the innate immune system and the type I interferon signature in patients with rheumatoid arthritis (RA), focusing on the heterogeneity of these signatures.
  • Researchers analyzed the expression of various innate genes in blood samples from 67 RA patients and 55 healthy controls, identifying different expression profiles associated with active and inactive disease.
  • Key findings revealed new deregulated genes (TLR10 and IL1RAP) in RA and identified four patient clusters based on immune gene expression, suggesting that this heterogeneity could influence disease progression and treatment outcomes.
View Article and Find Full Text PDF

There is the first evidence of changes in the kinetics of B cell antigen receptor (BCR) internalisation of neoplastic cells in chronic lymphocytic leukemia (CLL) after the short-term and long-term administration of ibrutinib. We aimed to assess the influence of short-term and long-term ibrutinib treatment on the HLA-DR expression on CLL cells, T cells and monocytes. The immunophenotyping of CLL and immune cells in peripheral blood was performed on 16 high-risk CLL patients treated with ibrutinib.

View Article and Find Full Text PDF